MSD Global Digital Validation Rollout

Executing on its visionary Global Quality Management Systems Strategy, industry leaders Merck Sharp & Dohme Corp. (MSD), a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA selected Kneat to digitalize seven validation work processes across two divisions (Manufacturing and Research) at 27 sites around the world.

As a result of this top-down corporate-led initiative, MSD achieved a “more than 50% cycle time reduction for test execution”, simplified process steps from 15 to just eight on average and eliminated reliance on three different quality management systems, generating “very significant value in dollars” for the organization.

Understand how, through this top-down, corporate-led project, MSD and Kneat partnered to achieve global end-to-end digitization of validation, enabling MSD to accelerate product launches, improve real-time regulatory data provision, and enable remote validation throughout COVID-19.

Cycle Time Reduction
Process Steps Eliminated
QMS Systems Made Obsolete

By 2022, the entire validation and qualification space will be in Kneat, end to end, at all sites. Kneat has become one of the foundational systems in QMS and beyond…for the users it’s a one-stop-shop.

Global Executive Director, QMS Technology Transfer & Commercialization, MSD

Talk to us

Find out how Kneat can make your validation easier, faster, and smarter.
Start your paperless validation revolution by speaking to our experts.

Europe: +353-61-203826
U.S: +1 888 88 KNEAT
Canada: +1 902 706 9074